← Open Payments lookup

ROSARY MUNOZ: Open Payments

NPI 1073814695 · BROWNSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$940 in 16 payments from 10 companies in 2025. Trend: 2023 $313 · 2024 $1,247 · 2025 $940

Food & beverage: $940
CompanyPaymentsAmount
Axsome Therapeutics, Inc.2$142
Alkermes, Inc.1$130
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$125
Otsuka America Pharmaceutical, Inc.1$123
Neurocrine BioSciences, Inc.5$115
ABBVIE INC.1$114
Teva Pharmaceuticals USA, Inc.1$109
Otsuka Pharmaceutical Development & Commercialization, Inc.2$39
E.R. Squibb & Sons, L.L.C.1$24
SCPHARMACEUTICALS INC.1$18

Products named: Auvelity, LYBALVI, CAPLYTA, REXULTI, INGREZZA, VRAYLAR, AUSTEDO XR, COBENFY.

Industry payments across TX — which companies pay providers there.